Coronavirus (COVID-19): Patient experience-Administrative services on the frontline during crisis.

Autor: Overton J; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Denton K; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Frumovitz M; Department of Gynecologic Oncology and Reconstructive Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Lewis C; Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Christensen S; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Bezerra J; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Hernandez C; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Walker MS; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Finder JP; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Proske AA; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Jain S; Department of Innovation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Whipple J; Department of Innovation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Martinez WL; Institute for Cancer Care Innovation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Eska JS; Institute for Cancer Care Innovation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Sutherland EW; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Triche LL; Division of Pediatrics, Patient Care, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Garcia EA; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA., Weber RS; Department of Patient Experience, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.; Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: Head & neck [Head Neck] 2020 Jul; Vol. 42 (7), pp. 1477-1481. Date of Electronic Publication: 2020 May 16.

Displacement of phenytoin from plasma binding sites by salicylate.

Autor: Fraser DG, Ludden TM, Evens RP, Sutherland EW 3rd

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 1980 Feb; Vol. 27 (2), pp. 165-9.

Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).

Autor: Golightly LK; University of Colorado Health Sciences Center, Denver., Smolinske SS, Bennett ML, Sutherland EW 3rd, Rumack BH

Publikováno v: Medical toxicology and adverse drug experience [Med Toxicol Adverse Drug Exp] 1988 Mar-Apr; Vol. 3 (2), pp. 128-65.

Phenytoin toxicity and blood levels after a large oral dose.

Autor: Evens RP, Fraser DG, Ludden TM, Sutherland EW 3rd

Publikováno v: American journal of hospital pharmacy [Am J Hosp Pharm] 1980 Feb; Vol. 37 (2), pp. 232-5.

Concepts for the rational selection of assays to be used in monitoring therapeutic drugs.

Autor: Werner M, Sutherland EW 3rd, Abramson FP

Publikováno v: Clinical chemistry [Clin Chem] 1975 Sep; Vol. 21 (10), pp. 1368-71.